Intravenous iron and recombinant human erythropoietin in cancer patients.
Beguin
Yves
Y
D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004347:Drug Interactions; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects* / Q000494:pharmacology; D009369:Neoplasms; D011788:Quality of Life; D011994:Recombinant Proteins; D015203:Reproducibility of Results; D012107:Research Design
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron